Public Employees Retirement Association of Colorado Sells 595 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Public Employees Retirement Association of Colorado decreased its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 9.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,439 shares of the company’s stock after selling 595 shares during the quarter. Public Employees Retirement Association of Colorado’s holdings in Prestige Consumer Healthcare were worth $425,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the company. Kestra Investment Management LLC acquired a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth approximately $27,000. CIBC Private Wealth Group LLC raised its holdings in shares of Prestige Consumer Healthcare by 48.9% during the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company’s stock worth $34,000 after buying an additional 152 shares in the last quarter. Headlands Technologies LLC bought a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth $40,000. Johnson Financial Group Inc. bought a new position in Prestige Consumer Healthcare in the fourth quarter valued at about $93,000. Finally, GAMMA Investing LLC raised its stake in Prestige Consumer Healthcare by 18.9% during the fourth quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock worth $108,000 after acquiring an additional 220 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Stock Up 1.6 %

Prestige Consumer Healthcare stock opened at $82.50 on Friday. The firm has a 50 day moving average price of $83.34 and a two-hundred day moving average price of $80.82. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. Prestige Consumer Healthcare Inc. has a 52-week low of $62.35 and a 52-week high of $90.04. The firm has a market cap of $4.09 billion, a price-to-earnings ratio of 19.32, a PEG ratio of 2.69 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH) last released its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Insider Activity at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of Prestige Consumer Healthcare stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the sale, the senior vice president now directly owns 17,157 shares in the company, valued at approximately $1,544,130. The trade was a 8.91 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of analysts have weighed in on PBH shares. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Tuesday. Royal Bank of Canada boosted their price objective on Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a “sector perform” rating in a research report on Friday, March 21st. Canaccord Genuity Group boosted their price target on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a report on Friday, February 7th. Oppenheimer raised their price objective on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a report on Thursday, February 13th. Finally, DA Davidson lifted their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $93.33.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.